There was a raised reporting of hyperglycaemias associated with PCSK9 inhibitors treatment compared to the full database (n = 1841/87,274 (2.1%); adjusted-reporting odds ratio (ROR) = 1.14 (1.07–1.22). The gene discussed is PCSK9; the disease is Hyperglycemia.